Subscribe to Updates for A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder
Stay informed about the latest developments in this trial. By subscribing, you will receive updates directly to your email. These updates will provide you with important information regarding any changes or progress related to the trial.
1/3
Tell us a little bit about yourself:
Fields marked with asterisk (*) are mandatory.

© 2025 Otsuka America Pharmaceutical,
Inc All rights reserved.
October 2025 01US25EUC0396
Requirements information